Akers Biosciences Inc (AKER):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Akers Biosciences Inc (AKER) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6533
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:89
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. ABI provides testing platform technologies, which include micro particle catalyzed biosensor, particle immune-filtration assay, rapid enzymatic assay, rapid blood cell separation, and synthetic macrocycle complex. The company serves medical clinicians, individuals, corporations, and law enforcement agencies, health professionals. ABI is headquartered in West Deptford, New Jersey, the US.

Akers Biosciences Inc (AKER) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Akers Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Akers Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Akers Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Akers Biosciences Inc, Medical Equipment, Deal Details 11
Partnerships 11
Akers Biosciences Enters into Distribution Agreement with Diagnostica Stago 11
Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 12
Akers Biosciences Enters into Distribution Agreement with Aero-Med 13
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 14
Akers Biosciences Enters into Distribution Agreement with Medline Industries 15
Akers Biosciences Enters into Distribution Agreement with Typenex 16
Equity Offering 17
Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 17
Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 18
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 19
Akers Biosciences Raises USD0.3 Million in Private Placement of Shares up on Exercise of Warrants 20
Akers Biosciences Raises USD2.1 Million in Private Placement of Shares upon Exercise of Warrants 21
Akers Biosciences Raises USD6.9 Million in Public Offering of Units 22
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 24
Akers Biosciences Plans to Raise up to USD3.6 Million in Public Offering of Shares 25
Akers Biosciences to Raise USD2 Million in Private Placement of Shares 26
Akers Biosciences Prices Public Offering of Shares and Warrants for USD2 Million 27
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 28
Akers Biosciences Inc – Key Competitors 29
Akers Biosciences Inc – Key Employees 30
Akers Biosciences Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 31
Recent Developments 32
Financial Announcements 32
Aug 14, 2018: Akers Biosciences announces Q2 and H1 2018 earnings 32
Jul 13, 2018: Akers Biosciences Announces Q1 2018 Earnings 40
Apr 03, 2018: Akers Biosciences Reports Earnings for Fiscal Year 2017 47
Nov 15, 2017: Akers Biosciences Announces Q3 2017 Earnings 52
Aug 15, 2017: Akers Biosciences: Financial Results for the Six Months Ended June 30, 2017 61
Aug 15, 2017: Akers Biosciences Announces Q2 2017 Earnings 63
Aug 03, 2017: Akers Biosciences Announces Second Quarter Trading Update 67
May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings 68
Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016 70
Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016 72
Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016 76
Corporate Communications 78
Sep 13, 2018: Akers Biosciences: Directorate change – form 8-K filing 78
May 29, 2018: Akers Biosciences Announces Board Change 79
Apr 26, 2018: Akers Biosciences: Directorate Change 80
Sep 07, 2017: Akers Biosciences Hires Medical Device Specialist to Lead US Sales and Distribution 81
Aug 08, 2017: Akers Biosciences Announces Board Changes 82
Legal and Regulatory 84
Jun 29, 2018: Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange 84
May 25, 2018: Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq 85
Product News 86
Apr 24, 2017: Akers Biosciences Updates on Akers Wellness Tests 86
Other Significant Developments 87
Oct 08, 2018: Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update 87
Appendix 89
Methodology 89
About GlobalData 89
Contact Us 89
Disclaimer 89

List of Tables
Akers Biosciences Inc, Medical Equipment, Key Facts, 2017 2
Akers Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Akers Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Akers Biosciences Inc, Deals By Market, 2012 to YTD 2018 9
Akers Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Akers Biosciences Enters into Distribution Agreement with Diagnostica Stago 11
Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 12
Akers Biosciences Enters into Distribution Agreement with Aero-Med 13
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 14
Akers Biosciences Enters into Distribution Agreement with Medline Industries 15
Akers Biosciences Enters into Distribution Agreement with Typenex 16
Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 17
Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 18
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 19
Akers Biosciences Raises USD0.3 Million in Private Placement of Shares up on Exercise of Warrants 20
Akers Biosciences Raises USD2.1 Million in Private Placement of Shares upon Exercise of Warrants 21
Akers Biosciences Raises USD6.9 Million in Public Offering of Units 22
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 24
Akers Biosciences Plans to Raise up to USD3.6 Million in Public Offering of Shares 25
Akers Biosciences to Raise USD2 Million in Private Placement of Shares 26
Akers Biosciences Prices Public Offering of Shares and Warrants for USD2 Million 27
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 28
Akers Biosciences Inc, Key Competitors 29
Akers Biosciences Inc, Key Employees 30
Akers Biosciences Inc, Subsidiaries 31
Akers Biosciences Inc, Joint Venture 31

List of Figures
Akers Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Akers Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Akers Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Akers Biosciences Inc (AKER):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Centrica Plc (CNA)-石油・ガス分野:企業M&A・提携分析
    Summary Centrica plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF Energy Nuclear Generation. Centrica secures and supply gas and electricity to homes a …
  • Norgine BV:企業の戦略的SWOT分析
    Norgine BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Village Super Market, Inc.:企業の戦略・SWOT・財務情報
    Village Super Market, Inc. - Strategy, SWOT and Corporate Finance Report Summary Village Super Market, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Heliatek GmbH:電力:M&Aディール及び事業提携情報
    Summary Heliatek GmbH (Heliatek) is a solar energy company that manufactures and constructs organic photovoltaics. The company manufactures modules on flexible substrates utilizing a roll-to-roll production process. Its products include OPV oligomers, OPV polymers, and OPV dye-sensitized solar cells …
  • Japan Foods Co Ltd:企業の戦略・SWOT・財務分析
    Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • National Institute of Neurological Disorders and Stroke-製薬・医療分野:企業M&A・提携分析
    Summary National Institute of Neurological Disorders and Stroke (NINDS), a subsidiary of National Institutes of Health is a healthcare research institute that conducts and supports research on brain and nervous system disorders. The institute’s clinical research areas include Alzheimer’s disease, br …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly known as Isotechnika Pharma Inc, develops and commercialization of therapies. The company pipeline product Voclosporin, is used for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS); and voclos …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Japan Post Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Japan Post Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Japan Post Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NorthWestern Corporation (NWE):石油・ガス:M&Aディール及び事業提携情報
    Summary NorthWestern Corp, doing business as NorthWestern Energy, is an electric and natural gas utility. It generates, transmits, and electricity, and also carries out mid-stream operations. The company produces from wind, hydro, solar, coal, and natural gas. NorthWestern Energy produces, stores, t …
  • Audentes Therapeutics Inc (BOLD):製薬・医療:M&Aディール及び事業提携情報
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …
  • Apotex, Inc.:企業の戦略・SWOT・財務情報
    Apotex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • INRange Systems Inc-医療機器分野:企業M&A・提携分析
    Summary INRange Systems Inc (INRange) is a medical device company that develops and markets remote management systems for the healthcare sector. The company provides remote medication management system to improve adherence to medication therapy by remotely managing, storing, delivering, and monitori …
  • Avadel Pharmaceuticals Plc (AVDL):製薬・医療:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …
  • NGM Biopharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical stage biopharmaceutical company which focuses on the development of drug discovery platform to generate biologic drug candidates to treat cardio-metabolic, immuno-oncology and liver diseases. Its product pipeline includes NGM282, NGM386, NGM …
  • CITIC Limited:企業の戦略・SWOT・財務情報
    CITIC Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Swelect Energy Systems Ltd (SWELECTES):電力:M&Aディール及び事業提携情報
    Summary Swelect Energy Systems Ltd (SESL), formerly Numeric Power Systems Ltd is an energy company that manufactures and markets renewable energy products and iron and steel products. The company’s renewable energy products include solar pv modules, solar inverter, solar water pump and energy effici …
  • Professional Insurance Corp Zambia PLC:企業の戦略・SWOT・財務分析
    Professional Insurance Corp Zambia PLC - Strategy, SWOT and Corporate Finance Report Summary Professional Insurance Corp Zambia PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Beverages & More Inc:企業の戦略的SWOT分析
    Beverages & More Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Total SA (FP):企業の財務・戦略的SWOT分析
    Total SA (FP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆